Literature DB >> 10703692

Apoptosis and formation of peroxynitrite in the lungs of patients with obliterative bronchiolitis.

P R Hansen1, A M Holm, U G Svendsen, P S Olsen, C B Andersen.   

Abstract

BACKGROUND: Obliterative bronchiolitis (OB) is the principal long-term complication of lung and heart-lung transplantation. OB is characterized histologically by inflammation, epithelial cell loss, fibrosis, and obliteration of the terminal airways. The contribution of apoptosis and peroxynitrite formation in OB was examined and assessed whether immunohistochemical markers of these reactions in transbronchial biopsy specimens were predictive of OB development.
METHODS: Pulmonary tissue samples from lung transplant recipients with OB (n = 5) or without OB (control group; n = 7) were investigated by in situ terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) and nitrotyrosine immunohistochemistry. Furthermore, TUNEL and nitrotyrosine expression was compared between matched transbronchial biopsy specimens from the two patient groups.
RESULTS: Sections with active OB displayed a significantly increased number of TUNEL-positive epithelial cells and macrophages compared with very little TUNEL in control specimens. TUNEL was almost absent in inactive OB. Nitrotyrosine was detected in all samples of pulmonary tissue, but nitrotyrosine expression was more intense in patients with active OB. There was no apparent temporospatial correlation of TUNEL and nitrotyrosine expression, and in matched transbronchial specimens, these immunohistochemical markers failed to identify patients with imminent risk of developing OB.
CONCLUSIONS: Apoptosis contributes to the pathophysiology of active OB but is apparently not directly paralleled by tissue peroxynitrite formation. In transbronchial biopsy specimens, markers of apoptosis and peroxynitrite formation are not valid predictors of OB and more studies are required to deliniate the role of these mechanisms in pulmonary allograft rejection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10703692     DOI: 10.1016/s1053-2498(99)00115-1

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  7 in total

Review 1.  Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling.

Authors:  Chun Geun Lee; Hye-Ryun Kang; Robert J Homer; Geoffrey Chupp; Jack A Elias
Journal:  Proc Am Thorac Soc       Date:  2006-07

2.  Chronic rejection of a lung transplant is characterized by a profile of specific autoantibodies.

Authors:  Peter H Hagedorn; Christopher M Burton; Jørn Carlsen; Daniel Steinbrüchel; Claus B Andersen; Eli Sahar; Eytan Domany; Irun R Cohen; Henrik Flyvbjerg; Martin Iversen
Journal:  Immunology       Date:  2010-02-26       Impact factor: 7.397

3.  Differential role of the Fas/Fas ligand apoptotic pathway in inflammation and lung fibrosis associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia and acute respiratory distress syndrome.

Authors:  Andrea D Lopez; Sreedevi Avasarala; Suman Grewal; Anuradha K Murali; Lucille London
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

4.  Apoptosis and the airway epithelium.

Authors:  Steven R White
Journal:  J Allergy (Cairo)       Date:  2011-12-13

Review 5.  Nitric oxide: a pro-inflammatory mediator in lung disease?

Authors:  A van der Vliet; J P Eiserich; C E Cross
Journal:  Respir Res       Date:  2000-08-15

6.  The Role of Lysophosphatidic Acid on Airway Epithelial Cell Denudation in a Murine Heterotopic Tracheal Transplant Model.

Authors:  Yukiko Tando; Chiharu Ota; Mitsuhiro Yamada; Satoshi Kamata; Mutsuo Yamaya; Kuniyuki Kano; Shinichi Okudaira; Junken Aoki; Hiroshi Kubo
Journal:  Transplant Direct       Date:  2015-10-19

7.  Upregulation of miR-146a increases cisplatin sensitivity of the non-small cell lung cancer A549 cell line by targeting JNK-2.

Authors:  Linrong Pang; Jinger Lu; Jia Huang; Caihong Xu; Hui Li; Guangbo Yuan; Xiaochun Cheng; Jun Chen
Journal:  Oncol Lett       Date:  2017-10-20       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.